NSF Awards U.S. Genomics a $500K Phase II-B SBIR Grant
News Oct 07, 2005
U.S. Genomics, Inc. has announced that it has received a Phase II-B SBIR grant from the National Science Foundation.
The $500,000 grant is earmarked for development of a commercial platform that uses the Company's rapid DNA analysis and genomic mapping technologies.
U.S. Genomics plans to use this installment to develop its Substance Identification and Quantitation Using Molecular Barcodes (SIQUMB) technology.
“This additional SBIR award recognizes the achievements we've made in developing single molecule analysis and genomic mapping for commercialization,” said John J. Canepa, acting Chief Executive Officer of U.S. Genomics.
“The ability to acquire and analyze molecular information has been made much more efficient with the invention of the SIQUMB molecular identification process.”
“This technology will be valuable for many commercial applications in life science research and in the healthcare industry.”
In July 2002, U.S. Genomics was awarded Phase I of the SBIR grant to create genomic maps by tagging and stretching individual DNA molecules.
During the Phase I project, U.S. Genomics achieved fundamental milestones by mapping long DNA molecules and substantially increasing the throughput and accuracy of the mapping technology.
In August 2003, the Company earned the subsequent Phase II grant. As part of the Phase II application, researchers at U.S. Genomics enhanced the capabilities of the DNA mapping platform and invented SIQUMB.
The recent award will enable U.S. Genomics to continue its development and commercialization of the SIQUMB technology.
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE